BSP Pharmaceuticals vs Lonza: CDMO Comparison
How does BSP Pharmaceuticals compare to Lonza for mRNA/LNP manufacturing?
Side-by-side comparison of BSP Pharmaceuticals and Lonza on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Lonza has more FDA inspections on record (11 vs 1) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- BSP Pharmaceuticals has materially broader EMA GMP coverage (15 active certificates vs 3) — stronger EU footprint.
- Lonza maintains 5 MHRA / UK GMP certificates; BSP Pharmaceuticals does not.
On a 13-modality CDMO landscape, both BSP Pharmaceuticals and Lonza qualify as mRNA/LNP manufacturers; BSP Pharmaceuticals carries the higher composite Signal Score for mRNA/LNP programs in this comparison.
What to evaluate for mRNA/LNP programs
Both BSP Pharmaceuticals and Lonza qualify as mRNA/LNP CDMOs. When choosing between them for mRNA/LNP programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.
Frequently asked: BSP Pharmaceuticals vs Lonza
How does BSP Pharmaceuticals compare to Lonza for mRNA/LNP manufacturing?
On CDMO Signal's composite Signal Score, BSP Pharmaceuticals is 78/100 and Lonza is 73/100; BSP Pharmaceuticals has 1 FDA inspection on record vs 11 for Lonza; European coverage is 15 active EMA+MHRA certificates for BSP Pharmaceuticals vs 8 for Lonza. Both are tracked in the CDMO Signal directory as mRNA/LNP CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, BSP Pharmaceuticals or Lonza?
Both BSP Pharmaceuticals and Lonza maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. BSP Pharmaceuticals has 1 FDA inspection on record; Lonza has 11.
How do BSP Pharmaceuticals and Lonza compare on European GMP coverage?
BSP Pharmaceuticals holds 15 active EMA GMP certificates and 0 MHRA / UK certificates. Lonza holds 3 active EMA GMP certificates and 5 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — BSP Pharmaceuticals or Lonza?
BSP Pharmaceuticals is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Lonza is matched to 1. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for mRNA/LNP manufacturing — BSP Pharmaceuticals or Lonza?
Both BSP Pharmaceuticals and Lonza are tagged as mRNA/LNP CDMOs in our directory, so both are credible options for mRNA/LNP programs. The most important differentiator for mRNA/LNP selection is typically ivt mrna synthesis: Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost. Review each CDMO's profile and inspection record before shortlisting.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →